KR

Healthcare · Pharmaceuticals

Krebs Biochemicals & Industries Ltd (KREBSBIO)

₹57.08

Mkt cap
₹128 Cr
P/E ratio
—
P/B
−0.72
Div yield
0.00%
ROE
—
ROCE
−15.40%
EPS (TTM)
—
Book value
−₹79
52W range
38–77
Sector
Healthcare

Price history

Previous close

Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.

NSE KREBSBIOBSE 524518
Health check
Mixed
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−25.73% from high
₹57
₹38+48.92% from low₹77
Current
₹57.08
Prev close
₹57.15
Day
−0.12%
Price performance
1D
−0.09%
1W
−3.60%
1M
−0.66%
3M
+3.44%
6M
+1.84%
1Y
−17.45%
YTD
−19.57%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales14.8912.9811.9712.8912.8611.476.105.484.177.276.816.985.79
YoY Sales growth-28.89%+42.79%+4.45%+21.83%-13.63%-11.63%-49.04%-57.49%-67.57%-36.62%+11.64%+27.37%+38.85%
Expenses15.7915.0715.0915.0815.5816.1811.517.576.976.977.676.167.72
Operating Profit-0.90-2.09-3.12-2.19-2.72-4.71-5.41-2.09-2.800.30-0.860.82-1.93
OPM %-6.04%-16.10%-26.07%-16.99%-21.15%-41.06%-88.69%-38.14%-67.15%4.13%-12.63%11.75%-33.33%
Other Income0.170.030.210.030.090.250.340.010.010.002.000.160.04
Interest1.131.191.271.321.421.561.611.651.731.791.911.881.90
Depreciation1.711.731.671.691.711.721.571.601.621.631.571.591.61
Profit before tax-3.57-4.98-5.85-5.17-5.76-7.74-8.25-5.33-6.14-3.12-2.34-2.49-5.40
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.24%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-3.57-4.98-5.85-5.17-5.76-7.74-8.27-5.32-6.14-3.13-2.34-2.48-5.40
EPS in Rs-1.66-2.31-2.71-2.40-2.67-3.59-3.84-2.47-2.85-1.45-1.09-1.15-2.50
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.55% · closed higher next day 1 of last 2
 Q1FY27†Q2FY27
Broadcast6 Aug '2629 Oct '26
Earnings day+0.97%−2.06%
+1 day+4.99%−4.31%
+5 days+0.17%−2.18%
+15 days+8.55%−3.47%
+30 days+3.14%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
72.74%Promoter
Promoters72.74%
FIIs0.50%
Public26.75%0.01
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Krebs Biochem₹59.23—1280.00%−5+12.05%6+38.85%−15.37%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings